QuickView for Propoxyphene (compound)

alpha-D-4-Dimethylamino-3-methyl-1,2-diphenyl-2-butanol-propionat [German]; (S)-alpha-(2-(Dimethylamino)-1-methylethyl)-alpha-phenylbenzeneethanol propanoate; Antalvic; (+)-1,2-Diphenyl-2-propionoxy-3-methyl-4-dimethylaminobutane; HSDB 3175; Dextropropoxyphene; EINECS 207-420-5; Femadol; 2-Butanol, 4-(dimethylamino)-3-methyl-1,2-diphenyl-, propionate, (+)-; Algafan.
show more »

alpha-D-4-Dimethylamino-3-methyl-1,2-diphenyl-2-butanol-propionat [German]; (S)-alpha-(2-(Dimethylamino)-1-methylethyl)-alpha-phenylbenzeneethanol propanoate; Antalvic; (+)-1,2-Diphenyl-2-propionoxy-3-methyl-4-dimethylaminobutane; HSDB 3175; Dextropropoxyphene; EINECS 207-420-5; Femadol; 2-Butanol, 4-(dimethylamino)-3-methyl-1,2-diphenyl-, propionate, (+)-; Algafan; Dextropropoxifeno [INN-Spanish]; 2-Butanol, 4-(dimethylamino)-3-methyl-1,2-diphenyl-, propionate (ester), (2S,3R)-; DEA No. 9273; Destropropossifene [DCIT]; 469-62-5; alpha-4-Dimethylamino-1,2-diphenyl-3-methyl-2-butanol propionate; Propoxyphene Darvon; C07406; Bulk dextropropoxyphene (non-dosage forms); Darvocet; Dextroproxifeno [Spanish]; Depromic; Proxagesic; Benzeneethanol, alpha-((1R)-2-(dimethylamino)-1-methylethyl)-alpha-phenyl-, propanoate (ester), (alphaS)-; (+)-4-Dimethylamino-1,2-diphenyl-3-methyl-2-propionyloxybutane; Dextropropoxyphenum [INN-Latin]; (D)-PROPOXYPHENE; Propoxyphene; 4-Dimethylamino-3-methyl-1,2-diphenyl-2-propoxybutane; d-Propoxyphene; SK 65; alpha-D-4-Dimethylamino-3-methyl-1,2-diphenyl-2-butanol propionate; alpha-(+)-4-Dimethylamino-1,2-diphenyl-3-methyl-2-propionoxybutane; Dextropropoxyphen; Propoxyphene, (+)-; alpha-(+)-4-Dimethylamino-1,2-diphenyl-3-methyl-2-butanol propionate ester; 3818-94-8; Benzeneethanol, alpha-(2-(dimethylamino)-1-methylethyl)-alpha-phenyl-, propanoate (ester), (S-(R*,S*))-; 21086-94-2
show less «

Dextropropoxyphene; Propoxyphene HCl; D-Propoxyphene; Dextropropoxyphene-M; Dextroproxifeno

Propoxyphene, a synthetic opiate agonist, is structurally similar to methadone. Its general pharmacologic properties are those of the opiates as a group. The analgesic effect of propoxyphene is due to the d-isomer, dextropropoxyphene. It binds to the opiate receptors and leads to a decrease of the perception of pain stimuli. Propoxyphene possesses ...
show more »

Propoxyphene, a synthetic opiate agonist, is structurally similar to methadone. Its general pharmacologic properties are those of the opiates as a group. The analgesic effect of propoxyphene is due to the d-isomer, dextropropoxyphene. It binds to the opiate receptors and leads to a decrease of the perception of pain stimuli. Propoxyphene possesses little to no antitussive activity and no antipyretic action.
show less «

Propoxyphene acts as a weak agonist at OP1, OP2, and OP3 opiate receptors within the central nervous system (CNS). Propoxyphene primarily affects OP3 receptors, which are coupled with G-protein receptors and function as modulators, both positive and negative, of synaptic transmission via G-proteins that activate effector proteins. Binding of the op...
show more »

Propoxyphene acts as a weak agonist at OP1, OP2, and OP3 opiate receptors within the central nervous system (CNS). Propoxyphene primarily affects OP3 receptors, which are coupled with G-protein receptors and function as modulators, both positive and negative, of synaptic transmission via G-proteins that activate effector proteins. Binding of the opiate stimulates the exchange of GTP for GDP on the G-protein complex. As the effector system is adenylate cyclase and cAMP located at the inner surface of the plasma membrane, opioids decrease intracellular cAMP by inhibiting adenylate cyclase. Subsequently, the release of nociceptive neurotransmitters such as substance P, GABA, dopamine, acetylcholine, and noradrenaline is inhibited. Opioids such as propoxyphene also inhibit the release of vasopressin, somatostatin, insulin, and glucagon. Opioids close N-type voltage-operated calcium channels (OP2-receptor agonist) and open calcium-dependent inwardly rectifying potassium channels (OP3 and OP1 receptor agonist). This results in hyperpolarization and reduced neuronal excitability.
show less «